Westermann’s group focused on H3K4me3 modifications, comparing INSM1-positive (Kelly, SK-N-FI, SKNDZ) and INSM1-negative (GI-ME-N, SH-EP) NB cell lines [22]. The gene discussed is INSM1; the disease is neuroblastoma.